The algorithm integrates with EHR systems and ECG platforms, operating within the health system without external data transfer.

Please provide your email address to receive an email when new articles are posted on . At diagnosis, the area under the receiver operating characteristic curve in two test sets was 0.92 and 0.88.

Anumana’s AI-enabled algorithm for the early detection of pulmonary hypertension (PH) has been cleared for use by the FDA.

A system-wide approach The new tool, called the UC Way Hypertension Medication Algorithm, follows a stepwise approach to increasing medication types and doses, while allowing clinicians to adjust ...

Anumana, a leader in cardiovascular AI, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its pulmonary hypertension (PH) algorithm, an AI-enabled software-as-a-medical-device ...

A special program developed by the University of California Health system and adopted at all six UC academic medical centers ...

Add Yahoo as a preferred source to see more of our stories on Google. PH is a progressive pulmonary vascular disease estimated to affect up to 1% of the global population. Credit: Orawan ...